Transmissibility of avian influenza viruses in mammals
禽流感病毒在哺乳动物中的传播能力
基本信息
- 批准号:8503049
- 负责人:
- 金额:$ 60.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAmino AcidsAnimalsAntibodiesAreaAvian Influenza A VirusBasic ScienceBindingBiologicalBiological AssayBirdsCase Fatality RatesDiseaseEgyptFerretsFoundationsFundingGenesGeneticGenetic TranscriptionH5 hemagglutininHeadHemagglutininHumanIncidenceIndonesiaInfectionInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H5N1 SubtypeInterferonsIntracellular TransportLibrariesMammalsModelingMolecularMonitorMusMutationOther GeneticsPathogenicityPopulationPropertyProteinsPublic HealthReassortant VirusesReportingResearchResearch DesignResearch Project GrantsRoleSpecificitySystemTestingTimeVietnamViral GenesVirusbaseinfluenzavirusmutantnovelpandemic diseasepublic health relevancereceptorreceptor bindingrespiratorytooltransmission process
项目摘要
DESCRIPTION (provided by applicant): Since 1997, highly pathogenic avian influenza viruses of the H5N1 subtype have infected humans with high case fatality rates, although no sustained human-to-human transmission has yet been reported. Currently, the molecular features and mechanisms that would result in human-to-human transmission of H5N1 viruses are not fully understood. Indeed, several attempts in the past to select transmissible H5 viruses (which typically do not transmit among mammals) were not successful, suggesting that influenza virus transmissibility is determined by several currently unknown factors. Recently, we screened H5 virus libraries possessing random mutations in the globular head region of the hemagglutinin (HA) protein and identified mutant H5 HAs that acquired the ability to bind to human-type receptors. These mutant H5 HAs did not support virus transmission among ferrets (an established influenza virus transmission model) via respiratory droplets, but acquired this ability
after two passages of the virus in these animals, which resulted in the selection of additional mutations in HA. This marks the first conversion of an H5 virus that does not transmit among ferrets into one with efficient respiratory droplet transmission. Based on this finding, we propose
to decipher the determinants of H5N1 virus transmission in mammals. In Aim 1, we plan "To Identify the Mechanisms That Control H5N1 Virus Transmissibility in Mammals". To gain a better understanding of the mutations in HA that result in transmissible viruses, we will select transmissible viruses based on H5 HA proteins derived from different subclades that have caused human infections. Our recent study suggested that HA stability may contribute to virus transmissibility. To test this concept, we also plan to identify mutations in HA that increase HA stability and then test these mutations for their significance in virus transmissibility. The HA proteins of all ferret-transmissible H5N1 viruses will then be characterized for their receptor-binding specificity, their structural consequences, their effects in other genetic backgrounds, and
their pathogenicity in mice and ferrets. Mutations in HA that allow avian influenza viruses to bind
to human-type receptors are most likely a prerequisite for transmission among mammals; however, findings by us and others indicate that human-type receptor binding is not sufficient for respiratory droplet transmission among ferrets, and that other viral genes also contribute to transmissibility. In Aim 2 ("To Characterize the Contribution of Viral Genes Other than HA to H5N1 Virus Transmissibility", we plan to passage non-transmissible viruses of different genetic backgrounds in ferrets to select transmissible mutants. Selected mutations will be characterized for their biological effects, using established assays for internalization, intracellular transport replication and transcription, assembly and budding, and interferon antagonism. Collectively, these studies are expected to generate critical information about the molecular determinants and mechanisms of H5N1 virus transmissibility in mammals.
描述(由申请人提供):自1997年以来,H5N1亚型的高度致病性禽流感病毒感染了病例高病情的人类,尽管尚未报道过持续的人类到人类传播。当前,尚未完全了解将导致人类到人类传播的分子特征和机制。实际上,过去有几次尝试选择可传播的H5病毒(通常在哺乳动物之间传播)并不成功,这表明流感病毒的传播性是由几种当前未知的因素确定的。最近,我们筛选了在血凝素(HA)蛋白的球形头部区域中具有随机突变的H5病毒文库,并鉴定出突变型H5具有与人型受体结合的能力。这些突变体H5不支持通过呼吸液滴(已建立的流感病毒传播模型)之间的病毒传播,但获得了这种能力
在这些动物中的病毒两次通过后,导致选择了HA中的其他突变。这标志着H5病毒的第一次转化,该病毒不会在雪貂之间传播到具有有效的呼吸液滴传递的一种中。基于这一发现,我们提出了
破译哺乳动物中H5N1病毒传播的决定因素。在AIM 1中,我们计划“确定控制哺乳动物中H5N1病毒传播的机制”。为了更好地了解导致可传播病毒的HA突变,我们将基于从引起人类感染的不同子基质中得出的H5 HA蛋白选择可传染性病毒。我们最近的研究表明,HA稳定性可能有助于病毒的传播。为了测试这个概念,我们还计划鉴定HA中增加HA稳定性的突变,然后测试这些突变在病毒传播中的重要性。然后,所有雪貂经过智能H5N1病毒的HA蛋白将以其受体结合特异性,结构后果,其他遗传背景的影响以及
它们在小鼠和雪貂中的致病性。 HA中允许禽流感病毒结合的突变
对人型受体很可能是哺乳动物传播的先决条件。但是,我们和其他人的发现表明,人类型受体结合不足以使雪貂之间的呼吸液滴传递,并且其他病毒基因也有助于传播。在目标2中(“为了表征HA对H5N1病毒传播的其他病毒基因的贡献”,我们计划通过雪貂的不同遗传背景的不同遗传背景的不可经常性病毒来选择可传播的突变体。将使用其生物学效应来表征其选择的突变,以实现其内部倾向,内部倾斜的三个研究和固定性的分类,并进行了固定的分类,并构成了固定的分类,并构成了固定的分类,并进行了构成,并构成了构建,并构成了启发。预计将产生有关哺乳动物中H5N1病毒传播性的分子决定因素和机制的关键信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOSHIHIRO KAWAOKA其他文献
YOSHIHIRO KAWAOKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOSHIHIRO KAWAOKA', 18)}}的其他基金
Development of broadly-protective vaccines for influenza B viruses
开发针对乙型流感病毒的广泛保护性疫苗
- 批准号:
10821572 - 财政年份:2023
- 资助金额:
$ 60.37万 - 项目类别:
Development of broadly-protective vaccines for influenza B viruses
开发针对乙型流感病毒的广泛保护性疫苗
- 批准号:
10206685 - 财政年份:2021
- 资助金额:
$ 60.37万 - 项目类别:
Development of broadly-protective vaccines for influenza B viruses
开发针对乙型流感病毒的广泛保护性疫苗
- 批准号:
10359831 - 财政年份:2021
- 资助金额:
$ 60.37万 - 项目类别:
COVID-19 comorbidity studies in Syrian hamster models
叙利亚仓鼠模型中的 COVID-19 合并症研究
- 批准号:
10450889 - 财政年份:2021
- 资助金额:
$ 60.37万 - 项目类别:
PanCorVac (Center for Pan-Coronavirus Vaccine Development)
PanCorVac(泛冠状病毒疫苗开发中心)
- 批准号:
10841731 - 财政年份:2021
- 资助金额:
$ 60.37万 - 项目类别:
COVID-19 comorbidity studies in Syrian hamster models
叙利亚仓鼠模型中的 COVID-19 合并症研究
- 批准号:
10285154 - 财政年份:2021
- 资助金额:
$ 60.37万 - 项目类别:
相似国自然基金
低蛋白日粮脂肪和蛋白质互作影响氨基酸消化率的机制
- 批准号:32302793
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
关键非催化氨基酸残基影响新型GH43家族双功能酶底物特异性的机制研究
- 批准号:32301052
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
孕期母体支链氨基酸代谢紊乱和子代支链氨基酸代谢酶基因遗传变异联合作用对儿童神经行为发育影响的队列研究
- 批准号:82373581
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
影响植物磷砷选择性吸收关键氨基酸位点的挖掘及分子机制研究
- 批准号:42307009
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
- 批准号:82370790
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Isoform- and Sex-Specific Functions of CGRP in Gastrointestinal Motility
CGRP 在胃肠动力中的亚型和性别特异性功能
- 批准号:
10635765 - 财政年份:2023
- 资助金额:
$ 60.37万 - 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 60.37万 - 项目类别:
Spatio-temporal mechanistic modeling of whole-cell tumor metabolism
全细胞肿瘤代谢的时空机制模型
- 批准号:
10645919 - 财政年份:2023
- 资助金额:
$ 60.37万 - 项目类别:
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 60.37万 - 项目类别:
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
在小鼠关节炎模型中验证新型肽的关节归巢和药物递送特性
- 批准号:
10589192 - 财政年份:2023
- 资助金额:
$ 60.37万 - 项目类别: